Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Experts establish standardized outcome measures for corneal neurotization
  • Neurotrophic Keratitis

Experts establish standardized outcome measures for corneal neurotization

Kelsey Moroz

An international panel of experts established standardized outcome measures for corneal neurotization, according to a poster presented at the 2025 World Cornea Congress.

Using a modified Delphi panel method, researchers conducted consensus-building activities through electronic surveys and a virtual meeting. Nineteen international experts from 7 countries participated in the process.

The panel agreed on key outcome measures, including corneal aesthesiometry, Mackie classification of neurotrophic keratitis, best corrected visual acuity, and donor site morbidity. In vivo confocal microscopy was recommended for evaluating the subbasal nerve plexus and intrastromal corneal nerves when available.

By establishing these standardized reporting guidelines, the study aims to facilitate more effective comparisons across different surgical techniques and patient populations.

Reference
Witsberger E, et al. Defining Outcomes of Corneal Neurotization Surgery: Consensus from the Corneal Neurotization Outcomes Delphi Study. Poster presented at: 2025 World Cornea Congress; March 20-22, 2025; Washington, DC.

Share

Related Content

  • Neurotrophic Keratitis

Serial DBM grafting improves outcomes in early neurotrophic keratitis

  • Neurotrophic Keratitis

Autologous serum eye drops improve symptoms and corneal nerve parameters in neurotrophic keratitis

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

  • Neurotrophic Keratitis

Systemic abnormalities commonly found in neurotrophic keratopathy patients, study finds

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon